{"issuance_frequency":"","notes_translated":{"fr":"Les vaccins contre la COVID-19 doivent être fabriqués conformément aux bonnes pratiques de fabrication (BPF). Ces conditions sont conformes aux exigences internationales, lesquelles sont décrites dans le document Lignes directrices - Thème Q7A de l'International Council for Harmonization et des lignes directrices applicables de Santé Canada.","en":"COVID-19 vaccines must be manufactured under good manufacturing practices (GMP) conditions. These conditions must be in line with international requirements, which are outlined in the International Council for Harmonization Q7A guideline and applicable Health Canada guidance."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"79d6adc7-a0e8-4702-92cf-fbe7923e27ae","metadata_created":"2021-07-29T12:12:26.844992","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-07-29T12:12:26.844998","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-07-29","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["coronavirus","COVID-19","pandémie","médicaments","médicaments","vaccins","autorisation de mise sur le marché","licence","importation ou vente","vaccin COVID-19","qualité","fabrication","exigences de libération des lots"],"en":["coronavirus","COVID-19","pandemic","drugs","medications","vaccines","market authorization","licensing","importing or selling","COVID-19 vaccine","quality","manufacturing","lot release requirements"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Lignes directrices sur les exigences relatives aux autorisations de mise en marché des vaccins contre la COVID-19 : Exigences de qualité, de fabrication et d’autorisation de mise en circulation des lots","en":"Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"79d6adc7-a0e8-4702-92cf-fbe7923e27ae","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"d8dc6834-1194-4aba-9c2b-abb9e46d4e9f","related_relationship":"","name_translated":{"fr":"Lignes directrices sur les exigences relatives aux autorisations de mise en marché des vaccins contre la COVID-19 : Exigences de qualité, de fabrication et d’autorisation de mise en circulation des lots","en":"Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements","language":["en"],"created":"2021-07-29T12:12:26.926842","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/guidance-market-authorization-vaccines/quality-manufacturing-lot-release-requirements.html","last_modified":null,"position":0,"revision_id":"72983beb-5b39-47db-966f-a5c7515862ab","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"79d6adc7-a0e8-4702-92cf-fbe7923e27ae","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"1207b4d9-fd43-453d-9beb-ee397a574a04","related_relationship":"","name_translated":{"fr":"Lignes directrices sur les exigences relatives aux autorisations de mise en marché des vaccins contre la COVID-19 : Exigences de qualité, de fabrication et d’autorisation de mise en circulation des lots","en":"Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements","language":["fr"],"created":"2021-07-29T12:12:26.926847","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/ligne-directrices-autorisations-mise-marche-vaccins/exigences-qualite-fabrication-autorisation-circulation-lots.html","last_modified":null,"position":1,"revision_id":"72983beb-5b39-47db-966f-a5c7515862ab","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2021-03-30 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"79d6adc7-a0e8-4702-92cf-fbe7923e27ae","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"COVID-19 vaccines must be manufactured under good manufacturing practices (GMP) conditions. These conditions must be in line with international requirements, which are outlined in the International Council for Harmonization Q7A guideline and applicable Health Canada guidance.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements","revision_id":"72983beb-5b39-47db-966f-a5c7515862ab"}